Lipocine Inc. — Director's Dealing 2014

Nov 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2014-11-14

Reporting Person: Patel Mahesh V. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-14	Common Stock	P	1900	$5.06	Acquired	881532	Direct
2014-11-14	Common Stock	P	100	$5.0599	Acquired	881632	Direct